Menopause

Health screening of healthy postmenopausal women

The impact of postmenopausal estrogen deprivation

Menopausal hormone therapy and the risk of breast cancer

Menopausal hormone therapy and the risk of cardiovascular

Preparation for menopausal hormone therapy

Choice of estrogen/progestin regimen

Other symptoms that respond to estrogen therapy

Use of Contraceptives during the menopausal transition

Stopping hormone therapy and tapering

Compounded bio-identical hormone therapy

Exercise role in prevention and treatment osteoporosis

Calcium/vitamin D supplementation in osteoporosis

Intensity of exercise

Fracture risk assessment

Candidates for treatment of osteoporosis and osteopenia in postmenopausal women

The use of bisphosphonates in postmenopausal women with osteoporosis

Contraindications/intolerance of bisphosphonates

Pretreatment evaluation of bisphosphonates therapy

Risk of bisphosphonate therapy in patient with osteoporosis

Combination therapy

When to initiate bisphosphonates

Fracture healing in patients already taking bisphosphonates

Guidelines for monitoring response to therapy

Bone mineral density stable or increased

Bone mineral density decreased or fracture during therapy

Parathyroid hormone/parathyroid hormone-related protein analog

Denosumab for osteoporosis

Selective estrogen receptor modulators (Raloxifene)

Calcitonin for osteoporosis

Isoflavones supplements

Risk factors of menopausal hotflashes

Duration of menopausal hotflashes

Clinical manifestations of menopausal hotflashes

Differential diagnosis of hotflashes

Menopausal hormone therapy in women with menopausal hotflashes

Bazedoxifene/conjugated estrogen for treatment of menopausal hotflashes

SSRIs/SNRIs for treatment of menopausal hotflashes

Gabapentin for treatment of menopausal hotflashes

Paroxetine for treatment of menopausal hotflashes

Clonidine for treatment of menopausal hotflashes

Depot medroxiprogesteron acetate for treatment of menopausal hotflashes

hotflashes in women with breast cancer

Plant based therapy for treatment of menopausal hotflashes

Acupuncture for treatment of menopausal hotflashes

Clonidine for treatment of menopausal hotflashes

Autoimmune endocrinopathies in women with premature menopause

Spontaneous ovulation in women with premature menopause

Role of estrogen, clomiphene, gonadotropin, glucocorticoid therapy in infertile women with POF

Approach to Management of women with POF

Contraception in women with premature menopause

Duration of therapy in women with premature menopause

Androgen replacement therapy in women with premature menopause

Etiology postmenopausal uterine bleeding

Risk factors endometrial cancer

Endometrial evaluation Endometrial biopsy Dilation and curettage Hysteroscopy Saline infusion sonohysterography Transvaginal ultrasound

Asymptomatic menopausal women with endometrial thickening

Asymptomatic menopausal women with fluid within the endometrial cavity

Endometrial thickening in women on hormone therapy

Endometrial thickening in women on tamoxifen

An ultrasound risk-scoring model for prediction of endometrial cancer in post-menopausal women

Endometrial hyperplasis: terminology and histologic class (2015, WHO)

Classification system Histologic category 2015 WHO Normal endometrium Hyperplasia without atypia (non-neoplastic) Atypical hyperplasia (neoplastic) Endometrial carcinoma 1994 WHO Simple hyperplasia without atypia Complex hyperplasia without atypia Simple Atypical hyperplasia (rare) Complex Atypical hyperplasia Endometrial intraepithelial neoplasia Benign endometrial hyperplasia Additional terms used in Proliferative endometrium Disordered proliferative endometrium Gland crowding

Management of proliferative endometrium

Management of nonatypical hyperplasia/benign endometrial hyperplasia (and some EIN)

Complex hyperplasia without atypia benign endometrial hyperplasia (some EIN)/gland crowding

Atypical hyperplasia/EIN

The end